V. Subbarayan et al., Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells, CANCER RES, 61(6), 2001, pp. 2720-2726
Cyclooxygenase (COX)-2 expression is elevated in some malignancies; however
, information is scarce regarding COX-2 contributions to the development of
prostate cancer and its regulation by inflammatory cytokines. The present
study compared and contrasted the expression levels and subcellular distrib
ution patterns of COX-1 and COX-2 in normal prostate [prostate epithelial c
ell (PrEC), prostate smooth muscle (PrSM), and prostate stromal (PrSt)] pri
mary cell cultures and prostatic carcinoma cell lines (PC-3, LNCaP, and DU1
45), The basal COX-2 mRNA and protein levels were high in normal PrEC and l
ow in tumor cells, unlike many other normal cells and tumor cells. Because
COX 2 levels were low in prostate smooth muscle cells, prostate stromal cel
ls, and tumor cells, we also examined whether COX-1 and COX-2 gene expressi
on was elevated in response to tumor necrosis factor-alpha (TNF-alpha), a s
trong inducer of COX-2 expression. Northern blot analysis and reverse trans
cription-PCR demonstrated different patterns and kinetics of expression for
COX-1 and COX-2 among normal cells and tumor cells in response to TNF-alph
a. In particular, COX-2 protein levels increased, and the subcellular distr
ibution formed a distinct perinuclear ring in the normal cells at 3 h after
TNF-alpha exposure. The COX-2 protein levels also increased in cancer cell
s, but the subcellular distribution was less organized; COX-2 protein appea
red diffuse in some cells and accumulated as focal deposits in the cytoplas
m of other cells, TNF-alpha induction of COX-2 and prostaglandin E-2 correl
ated inversely with induction of apoptosis. We conclude that COX-2 expressi
on may be important to PrEC cell function. Although it is low in stromal an
d tumor cells, COX-2 expression is induced by TNF-alpha in these cells, and
this responsiveness may play an important role in prostate cancer progress
ion.